| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |